Moreover, redox-sensitive transcription factors, such as Nrf2, when overexpressed in cancer, contributed to contrast oxidative stress also when induced by chemotherapeutic agents [33,34], thus preserve tumor environment and contribute to make MPM resistant to therapeutic approach. The gene discussed is NFE2L2; the disease is cancer.